Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs

Ann Rheum Dis. 2015 Feb;74(2):474-5. doi: 10.1136/annrheumdis-2014-206588. Epub 2014 Nov 28.
No abstract available

Keywords: DMARDs (biologic); Pharmacokinetics; Psoriatic Arthritis; Rheumatoid Arthritis.

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / blood*
  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / blood*
  • Arthritis, Psoriatic / blood
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / drug therapy*
  • Cohort Studies
  • Drug Therapy, Combination
  • Humans
  • Middle Aged

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab